Close Menu

NanoString

NanoString Technologies, Exiqon

New Product Watch: Jan 25, 2011

Premium

NanoString Technologies' nCounter Mouse miRNA Expression Assay Kit, Tecan's HydroSpeed Plate Washer, TriLink Biotechnologies' CleanAmp 7-deaza-dGTP Kit

ARUP Labs launches PAM50 Breast Cancer Intrinsic Classifier.

NanoString is betting that its test will predict treatment benefit for specific classes of chemotherapies, which will differentiate it from other genomic breast cancer tests on the market.

Bioclassifier has licensed to NanoString the rights to develop in vitro diagnostic and research products based on the so-called PAM50 gene signature and NanoString's nCounter platform. Meantime, ARUP Laboratories will next month launch a laboratory-developed qPCR test based on the signature.

CEO Brad Gray said that the firm intends to have the breast cancer intrinsic subtyping assay on the US market for clinical use in two years.

NanoString licensed a gene signature created and validated by Bioclassifier in order to develop diagnostic and research products for breast cancer intrinsic subtyping.

The grants, awarded through the Qualifying Therapeutic Discovery Project Program created by the Patient Protection and Affordable Care Act of 2010, were disclosed last week by the IRS.

Product Watch: Nov 4, 2010

Premium

Qiagen's FFPE kits, NuGen's Ovation FFPE kits, NanoString's nCounter Copy Number Variation CodeSets, Illumina's TruSeq sample-prep kits, the Agilent SureSelect XT Target Enrichment System

New Product Watch: Nov 2, 2010

Premium

NanoString Technologies' nCounter Copy Number Variation CodeSets, Schott's Nexterion MTP-NC96 Microplates

Pages

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.